BCL6 Antikörper (AA 200-401)
Kurzübersicht für BCL6 Antikörper (AA 200-401) (ABIN5027051)
Target
Alle BCL6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 200-401
-
Aufreinigung
- Protein G Chromatography
-
Immunogen
- A partial length recombinant BCL-6 protein (amino acids 200-401) was used as the immunogen for this antibody.
-
Isotyp
- IgG2b kappa
-
-
-
-
Applikationshinweise
- WB: 2-4 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS containing 0.05 % BSA, PH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
-
-
- BCL6 (B-Cell CLL/lymphoma 6 (BCL6))
-
Andere Bezeichnung
- BCL-6
-
Hintergrund
- BCL6 (B-cell lymphoma 6) is a 95 kDa zinc finger transcription factor and contains an N-terminal POZ domain. BCL6 is a transcriptional repressor and a master regulator of the germinal center (GC) B cell phenotype controlling its development and growth. BCL-6 modulates IL-4, BCR, and CD40L signals for normal B cell development. Altered BCL6 protein expression is implicated in pathogenesis of diverse human hematologic malignancies, especially in the diffuse large B cell lymphoma (DLBCL), the most common lymphoma in adults. BCL6 suppresses the expression of p53 (also known as tp53) tumor suppressor gene and modulates DNA damage-induced apoptotic responses in GC B cells.
-
Molekulargewicht
- 72 kDa
-
Gen-ID
- 604
-
UniProt
- P41182
-
Pathways
- Chromatin Binding, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Protein targeting to Nucleus
Target
-